Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Carladenise Armbrister Edwards is Director at Clover Health Investments, Corp.. OQRO lists 1 transaction filed with the SEC under this name, the latest on Mar 11, 2025, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Clover Health Investments, Corp.CLOV
Mar 7, 2025Sold~$722Kdisclosed Mar 11
DetailsOfficial recordAs of the latest filing on , Carladenise Armbrister Edwards reported holding 273,227 shares of Clover Health Investments, Corp. (CLOV), worth about $1.14M at the last close of $4 (Nov 18, 2026).
| Company | Shares reported | How held | Last close | Value at last close | Reported |
|---|---|---|---|---|---|
| Clover Health Investments, Corp. CLOV | 273,227 | 273K direct | $4 | $1.14M | Mar 7, 2025 |
Is this Carladenise Armbrister Edwards’s net worth? No. A Form 4 reports the shares an insider owns in one company after each transaction, directly or through trusts and entities. It says nothing about cash, other investments, property or debt, options not yet exercised are not counted here, and a holding reported some time ago may have changed without a new filing. The value is shares times the last stored close, not a price anyone received. Sources: the filings listed below, each linked to EDGAR. Compare with the biggest insider stakes.
Carladenise Armbrister Edwards has no open-market purchase on record since 2025. Sales in 1 of the 2 years since 2025.
Carladenise Armbrister Edwards reported 0 open-market purchases and 1 sale since 2025; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2025 | — | $722K1×1 trade |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Carladenise Armbrister Edwards reported 0 open-market purchases and 1 sale here, 2025.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
On the latest SEC Form 4, dated Mar 7, 2025, Carladenise Armbrister Edwards reported holding 273,227 shares of Clover Health Investments, Corp. (CLOV). At the last close of $4 on Nov 18, 2026, that is about $1.14M. This is the stake disclosed in filings, not a net worth.
No public filing gives Carladenise Armbrister Edwards's net worth. What SEC Form 4 shows is the stock stake: 273,227 shares of Clover Health Investments, Corp. (CLOV), about $1.14M at the last close. Cash, other investments, property, debts and unexercised options are not in these filings, so the real figure can be much higher or lower.
Carladenise Armbrister Edwards has no open-market purchase on record since 2025. Sales in 1 of the 2 years since 2025.
In SEC filings since 2025: no open-market purchase is on record; the latest open-market sale is from 2025.
Clover Health Investments, Corp. (CLOV), from 2025 to 2025: 0 purchases and 1 sale.